Proteome changes in the plasma of myelodysplastic syndrome patients with refractory anemia with excess blasts subtype 2

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Majek, Pavel ^a   Riedelova Reicheltova, Zuzana ^a   Suttnar, Jiri ^a   Pecankova, Klara ^a   Cermak, Jaroslav ^a   Dyr, Jan E ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ANGIOTENSINOGEN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; BETA2 GLYCOPROTEIN 1; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CLUSTERIN; COMPLEMENT COMPONENT C9; COMPLEMENT FACTOR I; FETUIN A; FICOLIN 2; HAPTOGLOBIN; HEMOPEXIN; INTER ALPHA TRYPSIN INHIBITOR HEAVY CHAIN H4 PROTEIN; KININOGEN I; LEUCINE RICH ALPHA 2 GLYCOPROTEIN; PROTEOME; PROTHROMBIN; SERUM ALBUMIN; TETRANECTIN; TRANSCORTIN; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT; PLASMA PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MYELODYSPLASTIC SYNDROME; PRINCIPAL COMPONENT ANALYSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REFRACTORY ANEMIA WITH EXCESS BLASTS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; ADULT; AGED; BLOOD; CASE CONTROL STUDY; CHEMISTRY; FEMALE; MALE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; YOUNG ADULT;

ADULT; AGED; AMINO ACID SEQUENCE; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE ANNOTATION; MYELODYSPLASTIC SYNDROMES; PEPTIDE FRAGMENTS; PROTEOME; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84902153697     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/178709     Document Type: Article

References (35)

1. Belickova M., Merkerova M. D., Stara E., Vesela J., Sponerova D., Mikulenkova D., Brdicka R., Neuwirtova R., Jonasova A., Cermak J., DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population. Journal of Hematology and Oncology 2013 6 1, article 9 2-s2.0-84872469877 10.1186/1756-8722-6-9
2. Merkerova M. D., Bystricka D., Belickova M., Krejcik Z., Zemanova Z., Polak J., Hajkova H., Brezinova J., Michalova K., Cermak J., From cryptic chromosomal lesions to pathologically relevant genes: integration of SNP-array with gene expression profiling in myelodysplastic syndrome with normal karyotype. Genes Chromosomes and Cancer 2012 51 5 419 428 2-s2.0-84857997094 10.1002/gcc.21927
3. Cechova H., Lassuthova P., Novakova L., Belickova M., Stemberkova R., Jencik J., Stankova M., Hrabakova P., Pegova K., Zizkova H., Cermak J., Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia. Neoplasma 2012 59 2 168 174 2-s2.0-84863848051 10.4149/neo-2012-022
4. Raza A., Galili N., The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes. Nature Reviews Cancer 2012 12 12 849 859 2-s2.0-84870221419 10.1038/nrc3321
5. Rodriguez-Emmenegger C., Houska M., Alles A. B., Brynda E., Surfaces resistant to fouling from biological fluids: towards bioactive surfaces for real applications. Macromolecular Bioscience 2012 12 10 1413 1422 2-s2.0-84867207820 10.1002/mabi.201200171
6. Riedel T., Brynda E., Dyr J. E., Houska M., Controlled preparation of thin fibrin films immobilized at solid surfaces. Journal of Biomedical Materials Research Part A 2009 88 2 437 447 2-s2.0-58149394401 10.1002/jbm.a.31755
7. Emmenegger C. R., Brynda E., Riedel T., Sedlakova Z., Houska M., Alles A. B., Interaction of blood plasma with antifouling surfaces. Langmuir 2009 25 11 6328 6333 2-s2.0-66749162630 10.1021/la900083s
8. Riedel T., Riedelová-Reicheltová Z., Májek P., Rodriguez-Emmenegger C., Houska M., Dyr J. E., Brynda E., Complete identification of proteins responsible for human blood plasma fouling on poly(ethylene glycol)-based surfaces. Langmuir 2013 29 10 3388 3397 2-s2.0-84874869125 10.1021/la304886r
9. Májek P., Riedelová-Reicheltová Z., Suttnar J., Pečánková K., Čermák J., Dyr J. E., Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome. Proteome Science 2013 11 1, article 14 2-s2.0-84875831952 10.1186/1477-5956-11-14
10. Májek P., Reicheltová Z., Suttnar J., Čermák J., Dyr J. E., Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia. Proteome Science 2011 9, article 64 2-s2.0-80053508377 10.1186/1477-5956-9-64
11. Májek P., Reicheltová Z., Suttnar J., Čermák J., Dyr J. E., Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome. Proteome Science 2012 10 1, article 31 2-s2.0-84860647859 10.1186/1477-5956-10-31
12. Malcovati L., Germing U., Kuendgen A., Della Porta M. G., Pascutto C., Invernizzi R., Giagounidis A., Hildebrandt B., Bernasconi P., Knipp S., Strupp C., Lazzarino M., Aul C., Cazzola M., Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. Journal of Clinical Oncology 2007 25 23 3503 3510 2-s2.0-34548219420 10.1200/JCO.2006.08.5696
13. Vardiman J. W., Harris N. L., Brunning R. D., The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002 100 7 2292 2302 2-s2.0-0036786901 10.1182/blood-2002-04-1199
14. Májek P., Reicheltová Z., Štikarová J., Suttnar J., Sobotková A., Dyr J. E., Proteome changes in platelets activated by arachidonic acid, collagen, and thrombin. Proteome Science 2010 8, article 56 2-s2.0-78149304710 10.1186/1477-5956-8-56
15. Lange V., Picotti P., Domon B., Aebersold R., Selected reaction monitoring for quantitative proteomics: a tutorial. Molecular Systems Biology 2008 4, article 222 2-s2.0-54049090766 10.1038/msb.2008.61
16. Kay R., Barton C., Ratcliffe L., Matharoo-Ball B., Brown P., Roberts J., Teale P., Creaser C., Enrichment of low molecular weight serum proteins using acetonitrile precipitation for mass spectrometry based proteomic analysis. Rapid Communications in Mass Spectrometry 2008 22 20 3255 3260 2-s2.0-58149195769 10.1002/rcm.3729
17. Májek P., Reicheltová Z., Suttnar J., Malý M., Oravec M., Pečánková K., Dyr J. E., Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1. Journal of Translational Medicine 2011 9, article 84 2-s2.0-79957658070 10.1186/1479-5876-9-84
18. Schneider C. A., Rasband W. S., Eliceiri K. W., NIH Image to ImageJ: 25 years of image analysis. Nature Methods 2012 9 7 671 675 2-s2.0-84863205849 10.1038/nmeth.2089
19. Ma W., Kantarjian H., Bekele B., Donahue A. C., Zhang X., Zhang Z. J., O'Brien S., Estey E., Estrov Z., Cortes J., Keating M., Giles F., Albitar M., Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome. Clinical Cancer Research 2009 15 11 3820 3826 2-s2.0-66649101365 10.1158/1078-0432.CCR-08-3034
20. Abdullah-Soheimi S. S., Lim B.-K., Hashim O. H., Shuib A. S., Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin. Proteome Science 2010 8, article 58 2-s2.0-78249255513 10.1186/1477-5956-8-58
21. Yoshida Y., Takahashi Y., Yoshikawa T., Nonomura A., Yoshioka A., Suppressive effect of α 2 Heremans-Schmid glycoprotein on in vitro calcification of osteogenesis. Pediatrics International 2006 48 1 11 16 2-s2.0-33645231660 10.1111/j.1442-200X.2006.02170.x
22. Lebreton J. P., Joisel F., Raoult J. P., Lannuzel B., Rogez J. P., Humbert G., Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process. Evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. Journal of Clinical Investigation 1979 64 4 1118 1129 2-s2.0-0018673697
23. Daveau M., Davrinche C., Julen N., Hiron M., Arnaud P., Lebreton J.-P., The synthesis of human α -2-HS glycoprotein is down-regulated by cytokines in hepatoma HepG2 cells. FEBS Letters 1988 241 1-2 191 194 2-s2.0-0024202110 10.1016/0014-5793(88)81059-7
24. Petrik V., Saadoun S., Loosemore A., Hobbs J., Opstad K. S., Sheldon J., Tarelli E., Howe F. A., Bell B. A., Papadopoulos M. C., Serum α 2-HS glycoprotein predicts survival in patients with glioblastoma. Clinical Chemistry 2008 54 4 713 722 2-s2.0-42449150835 10.1373/clinchem.2007.096792
25. O'Donnell L. C., Druhan L. J., Avalos B. R., Molecular characterization and expression analysis of leucine-rich α 2-glycoprotein, a novel marker of granulocytic differentiation. Journal of Leukocyte Biology 2002 72 3 478 485 2-s2.0-0036745069
26. Serada S., Fujimoto M., Terabe F., Iijima H., Shinzaki S., Matsuzaki S., Ohkawara T., Nezu R., Nakajima S., Kobayashi T., Plevy S. E., Takehara T., Naka T., Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis. Inflammatory Bowel Diseases 2012 18 11 2169 2179 2-s2.0-84867573123 10.1002/ibd.22936
27. Gazouli M., Anagnostopoulos A. K., Papadopoulou A., Vaiopoulou A., Papamichael K., Mantzaris G., Theodoropoulos G. E., Anagnou N. P., Tsangaris G. T., Serum protein profile of Crohn's disease treated with infliximab. Journal of Crohn's and Colitis 2013 7 e461 e470 2-s2.0-84875547908 10.1016/j.crohns.2013. 02.021
28. Liu Y., Luo X., Hu H., Wang R., Sun Y., Zeng R., Chen H., Integrative Proteomics and Tissue Microarray Profiling Indicate the Association between Overexpressed Serum Proteins and Non-Small Cell Lung Cancer. PLoS ONE 2012 7 12 2-s2.0-84871269094 10.1371/journal.pone.0051748 e51748
29. Kentsis A., Ahmed S., Kurek K., Brennan E., Bradwin G., Steen H., Bachur R., Detection and diagnostic value of urine leucine-rich α -2-glycoprotein in children with suspected acute appendicitis. Annals of Emergency Medicine 2012 60 1 78 83 2-s2.0-84862666573 10.1016/j.annemergmed.2011.12.015
30. Wang X., Abraham S., McKenzie J. A. G., Jeffs N., Swire M., Tripathi V. B., Luhmann U. F. O., Lange C. A. K., Zhai Z., Arthur H. M., Bainbridge J. W. B., Moss S. E., Greenwood J., LRG1 promotes angiogenesis by modulating endothelial TGF- β signalling. Nature 2013 499 7458 306 311 2-s2.0-84880427962 10.1038/nature12345
31. Riedel T., Rodriguez-Emmenegger C., de los Santos Pereira A., Bedajankova A., Jinoch P., Boltovets P. M., Brynda E., Diagnosis of Epstein-Barr virus infection in clinical serum samples by an SPR biosensor assay. Biosensors and Bioelectronics 2014 55 278 284
32. Rodriguez-Emmenegger C., Hasan E., Pop-Georgievski O., Houska M., Brynda E., Alles A. B., Controlled/living surface-initiated ATRP of antifouling polymer brushes from gold in PBS and blood sera as a model study for polymer modifications in complex biological media. Macromolecular Bioscience 2012 12 4 525 532 2-s2.0-84859723875 10.1002/mabi.201100425
33. Mariani S., Minunni M., Surface plasmon resonance applications in clinical analysis. Analytical and Bioanalytical Chemistry 2014 406 2303 2323
34. McGrath T. F., Buijs J., Huet A. C., Delahaut P., Elliott C. T., Mooney M. H., Assessment of a multiplexing high throughput immunochemical SPR biosensor in measuring multiple proteins on a single biosensor chip. Sensors and Actuators B 2013 186 423 430 2-s2.0-84880065494 10.1016/j.snb.2013.06.002
35. Fracchiolla N. S., Artuso S., Cortelezzi A., Biosensors in clinical practice: focus on oncohematology. Sensors 2013 13 5 6423 6447 2-s2.0-84878031324 10.3390/s130506423